Scarica l'app Stockscreener
111.42
0.69%
0.76
Dopo l'orario di chiusura:
111.42
Precedente Chiudi:
$110.66
Aprire:
$110.83
Volume 24 ore:
798.21K
Relative Volume:
0.46
Capitalizzazione di mercato:
$8.51B
Reddito:
$8.10B
Utile/perdita netta:
$599.48M
Rapporto P/E:
15.06
EPS:
7.3969
Flusso di cassa netto:
$971.54M
1 W Prestazione:
+11.43%
1M Prestazione:
+3.03%
6M Prestazione:
-42.06%
1 anno Prestazione:
-33.11%
Intervallo 1D:
$110.33
$112.94
Intervallo di 1 settimana:
$100.25
$112.94
Portata 52W:
$66.57
$211.00
Icon Plc Stock (ICLR) Company Profile
Nome
Icon Plc
Settore
Industria
Telefono
-
Indirizzo
-
Compare ICLR vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
111.42 | 8.45B | 8.10B | 599.48M | 971.54M | 7.3969 |
TMO
Thermo Fisher Scientific Inc
|
494.54 | 182.60B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
190.79 | 134.18B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
564.66 | 44.63B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.54 | 32.21B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
299.89 | 29.21B | 3.17B | 642.63M | 516.49M | 10.77 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-26 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2026-02-23 | Aggiornamento | Jefferies | Hold → Buy |
| 2026-02-18 | Aggiornamento | TD Cowen | Hold → Buy |
| 2026-02-17 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| 2026-02-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2026-02-12 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2026-01-08 | Downgrade | Truist | Buy → Hold |
| 2025-12-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-11-13 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-09-09 | Downgrade | Jefferies | Buy → Hold |
| 2025-09-03 | Aggiornamento | Rothschild & Co Redburn | Neutral → Buy |
| 2025-08-21 | Downgrade | Citigroup | Buy → Neutral |
| 2025-07-24 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-04-29 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-04-14 | Downgrade | TD Cowen | Buy → Hold |
| 2025-04-10 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-03-21 | Downgrade | Goldman | Buy → Neutral |
| 2025-01-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-10-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Iniziato | Redburn Atlantic | Neutral |
| 2024-09-18 | Iniziato | Leerink Partners | Outperform |
| 2024-06-06 | Iniziato | Goldman | Buy |
| 2023-12-15 | Iniziato | Truist | Buy |
| 2023-09-13 | Iniziato | TD Cowen | Outperform |
| 2023-01-17 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2023-01-13 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-11-09 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-09-07 | Iniziato | UBS | Buy |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-05-24 | Iniziato | Guggenheim | Buy |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-12 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2021-09-27 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-23 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-07-14 | Iniziato | Citigroup | Neutral |
| 2021-04-13 | Ripresa | BofA Securities | Neutral |
| 2021-04-01 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-03-08 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-03-03 | Iniziato | Barclays | Equal Weight |
| 2021-03-01 | Aggiornamento | UBS | Neutral → Buy |
| 2021-02-26 | Aggiornamento | Truist | Hold → Buy |
| 2020-07-24 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-04-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-03-02 | Iniziato | Deutsche Bank | Hold |
| 2020-01-27 | Downgrade | SunTrust | Buy → Hold |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-09-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-07-26 | Aggiornamento | UBS | Sell → Neutral |
| 2019-01-25 | Aggiornamento | Mizuho | Neutral → Buy |
| 2018-10-26 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-10-09 | Iniziato | UBS | Sell |
| 2018-04-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2018-02-15 | Reiterato | Mizuho | Neutral |
| 2018-01-19 | Iniziato | Evercore ISI | Outperform |
| 2017-10-27 | Reiterato | Barclays | Equal Weight |
| 2017-09-11 | Iniziato | BofA/Merrill | Buy |
| 2017-07-31 | Aggiornamento | SunTrust | Hold → Buy |
| 2017-07-27 | Reiterato | Mizuho | Neutral |
| 2017-06-29 | Aggiornamento | Jefferies | Hold → Buy |
Mostra tutto
Icon Plc Borsa (ICLR) Ultime notizie
MEX:ICLR EV-to-OCF: 9.32 — 56% Below Median - GuruFocus
Icon PLC Forges Strategic Alliance Amidst Financial Review - AD HOC NEWS
Icon Plc $ICLR Shares Bought by Allspring Global Investments Holdings LLC - MarketBeat
Icon PLC (ICLR) Stock Price Up 3.93% on Mar 30 - GuruFocus
Precision Trading with Icon Plc (ICLR) Risk Zones - news.stocktradersdaily.com
Is ICON Public Limited Company (ICLR) A Good Stock To Buy Now? - Insider Monkey
ICON Stock Trades At Deep Discount Amid Probe - Let's Data Science
Icon Plc (NASDAQ:ICLR) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Why ICON (ICLR) Is Up 5.1% After New AI-Powered Clinical Trial Partnership With Advarra - simplywall.st
Analysts Offer Insights on Healthcare Companies: Icon (ICLR) and Journey Medical Corp (DERM) - theglobeandmail.com
Clinical research provider Icon stock crashes on accounting probe - MSN
ICON (ICLR) Upgraded by BMO Capital Markets Amid Valuation Appea - GuruFocus
Icon plc buy BMO Capital Markets - sharewise.com
ICON PLC : BMO Raises to Outperform From Mark - Moomoo
BMO Capital Upgrades Icon PLC(ICLR.US) to Buy Rating, Cuts Target Price to $130 - 富途牛牛
BMO upgrades ICON stock rating on pharma backdrop improvement - Investing.com UK
Strategic Partnership Aims to Boost Icon's Efficiency Amid Accounting Scrutiny - AD HOC NEWS
WGI DM, LLC's Icon PLC(ICLR) Holding History - GuruFocus
Icon, Advarra enter partnership, introduces ‘research-ready’ site network model - TipRanks
ICON, Advarra Partner on Connected Site Network Model - Contract Pharma
ICON and Advarra Introduce New ‘Research-Ready,’ Connected Site Network Model (1) - PharmiWeb.com
Rep. Julia Letlow Sells Icon Plc (NASDAQ:ICLR) Stock - MarketBeat
ICON and Advarra Introduce New ‘Research-Ready,’ Connected Site Network Model - Business Wire
JPMorgan Chase & Co. Sells 614,165 Shares of Icon Plc $ICLR - MarketBeat
ICON set to report delayed earnings after accounting scandal - Investing.com UK
ICON set to report delayed earnings after accounting scandal By Investing.com - Investing.com UK
ICON (ICLR) Is Down 7.8% After Revenue Overstatement Disclosure And Accounting ReviewHas The Bull Case Changed? - Yahoo Finance
Icon Plc $ICLR is Wgi Dm LLC's 4th Largest Position - marketbeat.com
Hudson Bay Capital Management LP Sells 79,000 Shares of Icon Plc $ICLR - MarketBeat
ICON plc (ICLR) CEO details stock option and RSU holdings - Stock Titan
ICON PLC (ICLR) CFO lists RSU and stock option holdings in Form 3 - Stock Titan
ICON PLC (ICLR) director Stephen Cutler reports 79,278 shares and options - Stock Titan
[Form 3] ICON PLC Initial Statement of Beneficial Ownership - Stock Titan
ICON PLC (ICLR) director Linda Grais reports initial share and RSU holdings - Stock Titan
Director Anne Whitaker reports 1,732 ICON PLC (ICLR) restricted share units - Stock Titan
Julie O’Neill (ICLR) details initial ICON PLC share and RSU holdings - Stock Titan
ICON PLC (ICLR) director details shares, RSUs and option holdings - Stock Titan
ICON PLC (NASDAQ: ICLR) director Ronan Murphy details share and option holdings - Stock Titan
ICON PLC (ICLR) director Climax details options, RSUs and share stakes - Stock Titan
ICON PLC (ICLR) director reports initial Form 3 equity holdings - Stock Titan
CIBC Bancorp USA Inc. Invests $39.07 Million in Icon Plc $ICLR - MarketBeat
ICON plc Experiences Revision in Stock Evaluation Amid Mixed Technical Indicators - Markets Mojo
Holocene Advisors LP Sells 287,221 Shares of Icon Plc $ICLR - MarketBeat
Lowey Dannenberg Investigating ICON PLC for Potential Securities Violations - National Today
Lowey Dannenberg Investigating ICON PLC for Potential Securities Law Violations - National Today
Lowey Dannenberg, P.C. is Investigating ICON PLC (NASDAQ: ICLR) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm - marketscreener.com
Lowey Dannenberg, P.C. is Investigating ICON PLC (NASDAQ: - GlobeNewswire
Icon Plc $ICLR Shares Sold by Fayez Sarofim & Co - MarketBeat
Alliancebernstein L.P. Purchases 53,325 Shares of Icon Plc $ICLR - MarketBeat
ICON (ICLR) Is Down 10.6% After Revenue Restatement And Earnings Delay News Event Has The Bull Case Changed? - Sahm
ICON plc Stock Faces Binary Catalyst as Investigation Nears Verdict on April 30 - AD HOC NEWS
Icon Plc Azioni (ICLR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):